Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Chrysler Group Feb. U.S. Sales Climb 40% - Quick Facts

RELATED NEWS
Trade FCAU now with 

Chrysler Group LLC, majority owned by Italy-based Fiat SpA (FIATY.PK), on Thursday posted a 40 percent improvement in its February 2012 U.S. sales to 133,521 units from 95,102 units in February 2011.

In February, every Chrysler Group model in production for over 12 months posted a year-over-year sales gain and the Chrysler brand led the way with a solid 114 percent growth. The company said the FIAT brand finished its first year of sales with its best month ever, with Fiat 500 sales growing by 69 percent in February compared with the prior month.

Total car sales for the same month jumped 126% to 40,024 units from previous year's 17,745 units, and total truck sales went up 21% to 93,497 units from 77,357 units in the comparable period.

Click here to receive FREE breaking news email alerts for Fiat Chrysler Automobiles NV and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.